National Human Genome Research Institute; Notice of Closed Meeting, 75057 [2022-26588]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 234 / Wednesday, December 7, 2022 / Notices
ddrumheller on DSK6VXHR33PROD with NOTICES
institutes and centers. This process
produced many modifications and the
final proposal presented below.
Additional background information can
be found here https://grants.nih.gov/
policyroposed-Framework/index.htm.
Proposed Revised Simplified Review
Framework
An Overall Impact Score (scored 1–9)
will reflect the overall scientific and
technical merit of the application.
Reviewers will take into account their
assessments of the three factors below
and the following additional criteria in
determining an Overall Impact Score. Of
the three factors, only Factor 1:
Importance of the Research and Factor
2: Feasibility and Rigor, will receive
individual scores. In the revised
framework, Factor 3: Expertise and
Resources will not receive an individual
score. The additional review criteria
below will not receive individual scores
but will be considered in arriving at the
Overall Impact Score. Two review
considerations will be evaluated but
have no effect on the Overall Impact
Score. Detailed descriptions of the three
factors can be found here https://
grants.nih.gov/policyroposedFramework/reviewer-guidance.htm.
Factor 1: Importance of the Research
(scored 1–9).
Factor 1 is based on the criteria
Significance and Innovation.
Factor 2: Feasibility and Rigor (scored
1–9).
Factor 2 is based on the criteria
Approach.
Factor 3: Expertise and Resources
(rated as ‘‘fully capable’’, ‘‘appropriate’’
or ‘‘additional capability/expertise
needed’’ or ‘‘additional resources
needed’’)
Factor 3 is based on the criteria
Investigator and Environment. If
‘‘additional expertise/capability
needed’’ or ‘‘additional resources
needed’’ is selected, justification must
be provided.
Additional Criteria (not scored, but
affecting Overall Impact):
• Human Subject Protections
• Inclusion of Women, Minorities,
and Individuals Across the Lifespan
• Vertebrate Animals
• Biohazards
• Resubmission/Renewal/Revisions
Each of the Additional Criteria except
the last will be rated as ‘‘Appropriate’’,
with no comments required, or as
‘‘Concerns’’, which must be briefly
justified. Resubmission/Renewal/
Revisions will be given brief written
evaluations.
Additional Review Considerations
(not scored and having no effect on
Overall Impact):
VerDate Sep<11>2014
19:54 Dec 06, 2022
Jkt 259001
• Authentication of Key Biological and/
or Chemical Resources
• Rated as ‘‘Appropriate’’ with no
comments required, or as
‘‘Concerns’’, which must be briefly
described.
• Budget and Period of Support
• Rated as ‘‘Appropriate’’,
‘‘Excessive’’, or ‘‘Inadequate’’; the
latter two ratings requiring a brief
account of concerns.
The additional review considerations,
including Foreign Organizations, Select
Agents, and Resource Sharing Plans,
will no longer be evaluated by peer
reviewers.
Restructuring the categorization and
scoring of criteria in this way reduces
the number of scores reviewers need to
provide, and policy considerations
reviewers need to take into account
when evaluating scientific merit. It
focuses reviewers on the two most
important judgements about a proposed
research project; how important the
research is, and how rigorous and
feasible the approach is. Evaluation of
the investigators and research
environment is framed in terms of
whether the expertise and resources
needed to accomplish the project are
available, thus diminishing halo
effects— diffuse judgements of
investigator or institutional reputation
that bias judgements of research
importance, rigor, and feasibility.
Submitting a Response
Comments should be submitted
electronically to the following web page
at: https://rfi.grants.nih.gov/?s=
638509b5409baa49f803e572.
This RFI is for planning purposes
only and should not be construed as a
policy, solicitation for applications, or
as an obligation on the part of the
Government to provide support for any
ideas identified in response to it. Please
note that the Government will not pay
for the preparation of any information
submitted or for its use of that
information.
Please do not include any proprietary,
classified, confidential, or sensitive
information in your response.
Responses will be compiled and a
content analysis will be shared publicly
after the close of the comment period.
The NIH may use information gathered
by this Notice to inform future policy
development.
Dated: December 1, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2022–26603 Filed 12–6–22; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
75057
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: January 6, 2023.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Room 3185,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Room 3185,
Bethesda, MD 20892, (301) 402–8837,
barbara.thomas@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS).
Dated: December 2, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–26588 Filed 12–6–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\07DEN1.SGM
07DEN1
]]>Agencies
[Federal Register Volume 87, Number 234 (Wednesday, December 7, 2022)]
[Notices]
[Page 75057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Inherited Disease Research Access
Committee.
Date: January 6, 2023.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 3100, Room 3185,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B Rockledge Drive,
Suite 3100, Room 3185, Bethesda, MD 20892, (301) 402-8837,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS).
Dated: December 2, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26588 Filed 12-6-22; 8:45 am]
BILLING CODE 4140-01-P
